Tech Company Financing Transactions

Neurona Therapeutics Funding Round

On 2/9/2024, Neurona Therapeutics raised $120 million in financing from Cormorant Asset Management, Viking Global Investors and Alexandria Venture Investments.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
The company intends to use the funds to advance its pipeline of wholly-owned, off-the-shelf cell therapies for multiple indications, including its lead investigational candidate, NRTX-1001.

Company Information

Company Status
Private & Independent
Mailing Address
170 Harbor Way
San Francisco, CA 94080
Email Address
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.
Neurona Therapeutics  LinkedIn Company Profile
Social Media
Neurona Therapeutics  Company Twitter Account
Company News
Neurona Therapeutics  News
Neurona Therapeutics  on Facebook
Neurona Therapeutics  on YouTube

Management Team

Email & Social
Timothy Kutzkey
  Timothy Kutzkey LinkedIn Profile  Timothy Kutzkey Twitter Account  Timothy Kutzkey News  Timothy Kutzkey on Facebook
Chief Executive Officer
Cory Nicholas
  Cory Nicholas LinkedIn Profile  Cory Nicholas Twitter Account  Cory Nicholas News  Cory Nicholas on Facebook
VP - Bus. Development
Michael Greenberg
  Michael Greenberg LinkedIn Profile  Michael Greenberg Twitter Account  Michael Greenberg News  Michael Greenberg on Facebook
VP - Bus. Development
Catherine Priest
  Catherine Priest LinkedIn Profile  Catherine Priest Twitter Account  Catherine Priest News  Catherine Priest on Facebook
VP - Finance
James Tanaka
  James Tanaka LinkedIn Profile  James Tanaka Twitter Account  James Tanaka News  James Tanaka on Facebook
VP - Human Resources
Celinda Moore
  Celinda Moore LinkedIn Profile  Celinda Moore Twitter Account  Celinda Moore News  Celinda Moore on Facebook
VP - Manufacturing
Gautam Banik
  Gautam Banik LinkedIn Profile  Gautam Banik Twitter Account  Gautam Banik News  Gautam Banik on Facebook
VP - Operations
Alessandro Bulfone
  Alessandro Bulfone LinkedIn Profile  Alessandro Bulfone Twitter Account  Alessandro Bulfone News  Alessandro Bulfone on Facebook
VP - Regulatory Affairs
Estela Alvarez
  Estela Alvarez LinkedIn Profile  Estela Alvarez Twitter Account  Estela Alvarez News  Estela Alvarez on Facebook
VP - Regulatory Affairs
Paurene Duramad
  Paurene Duramad LinkedIn Profile  Paurene Duramad Twitter Account  Paurene Duramad News  Paurene Duramad on Facebook
VP - Regulatory Affairs
Sergei Shevchuk
  Sergei Shevchuk LinkedIn Profile  Sergei Shevchuk Twitter Account  Sergei Shevchuk News  Sergei Shevchuk on Facebook



Browse more venture capital transactions:

Prev: 2/9/2024: Portchain venture capital transaction
Next: 2/9/2024: Myrspoven venture capital transaction


Share this article


Where The Data Comes From

We report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary